SCP Investment’s Allergan plc AGN Stock Holding History

SCP Investment’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-14,000	Closed	-$2.36M	–	76
2018 Q1	$2.36M	Buy	+14,000	New	+$2.35M	1.56%	21

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCP Investment's AGN Position: Q2 2018 in Review

SCP Investment sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 14,000 shares — an estimated $2.36M sold.

SCP Investment first reported a position in AGN in Q1 2018 and held it in 1 quarter. The position peaked at $2.36M in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

SCP Investment reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
SCP Investment sold 14,000 Allergan plc shares in Q2 2018, an estimated $2.36M.
SCP Investment first reported a position in Allergan plc in Q1 2018 and held it in 1 quarter.
SCP Investment's Allergan plc position peaked at $2.36M in Q1 2018.
1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on SCP Investment's 13F filing for Q2 2018, filed 15 Aug 2018.